GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 87 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $68,000 | +7.9% | 10,629 | -7.8% | 0.00% | – |
Q1 2018 | $63,000 | -14.9% | 11,522 | -34.6% | 0.00% | – |
Q4 2017 | $74,000 | +51.0% | 17,628 | +212.6% | 0.00% | – |
Q2 2016 | $49,000 | +88.5% | 5,640 | +13.5% | 0.00% | – |
Q1 2016 | $26,000 | -7.1% | 4,967 | +35.3% | 0.00% | – |
Q4 2015 | $28,000 | -28.2% | 3,671 | -25.2% | 0.00% | – |
Q3 2015 | $39,000 | +178.6% | 4,907 | +220.3% | 0.00% | – |
Q2 2015 | $14,000 | -12.5% | 1,532 | +27.5% | 0.00% | – |
Q1 2015 | $16,000 | 0.0% | 1,202 | +3.7% | 0.00% | – |
Q4 2014 | $16,000 | +23.1% | 1,159 | -17.4% | 0.00% | – |
Q3 2014 | $13,000 | -31.6% | 1,403 | 0.0% | 0.00% | – |
Q2 2014 | $19,000 | – | 1,403 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 950,000 | $9,823,000 | 1.01% |
Curi RMB Capital, LLC | 939,265 | $9,720,000 | 0.74% |
KOPP INVESTMENT ADVISORS LLC | 96,384 | $997,000 | 0.39% |
Alyeska Investment Group, L.P. | 314,502 | $3,254,000 | 0.16% |
PFM Health Sciences, LP | 604,199 | $6,252,000 | 0.13% |
Spark Investment Management LLC | 47,000 | $485,000 | 0.13% |
ELLINGTON MANAGEMENT GROUP LLC | 61,700 | $638,000 | 0.12% |
PUTNAM INVESTMENTS LLC | 1,745,494 | $18,048,000 | 0.05% |
PointState Capital LP | 298,976 | $3,094,000 | 0.05% |
Partner Investment Management, L.P. | 20,717 | $214,000 | 0.05% |